Developments in targeted therapy & immunotherapy—how non-small cell lung cancer management will change in the next decade: a narrative review

por Li, Molly S. C., Mok, Kevin K. S., Mok, Tony S. K.
Publicado 2023

Resistance-resistant antibacterial treatment strategies

por Batchelder, Jonathan I., Hare, Patricia J., Mok, Wendy W. K.
Publicado 2023

Testing for COVID-19 in lung cancer patients

por Passaro, A., Peters, S., Mok, T.S.K., Attili, I., Mitsudomi, T., de Marinis, F.
Publicado 2020

RNA Futile Cycling in Model Persisters Derived from MazF Accumulation

por Mok, Wendy W. K., Park, Junyoung O., Rabinowitz, Joshua D., Brynildsen, Mark P.
Publicado 2015

Enhanced antibiotic resistance development from fluoroquinolone persisters after a single exposure to antibiotic

por Barrett, Theresa C., Mok, Wendy W. K., Murawski, Allison M., Brynildsen, Mark P.
Publicado 2019

Selenite as a dual apoptotic and ferroptotic agent synergizes with EGFR and KRAS inhibitors with epigenetic interference

por Chan, Lok Seng, Liu, Johnson, Li, Molly S. C., Li, Lili, Tao, Qian, Mok, Tony S. K.
Publicado 2023

Non-Monotonic Survival of Staphylococcus aureus with Respect to Ciprofloxacin Concentration Arises from Prophage-Dependent Killing of Persisters

por Sandvik, Elizabeth L., Fazen, Christopher H., Henry, Theresa C., Mok, Wendy W.K., Brynildsen, Mark P.
Publicado 2015

Adjusted Indirect Comparison Using Propensity Score Matching of Osimertinib to Platinum-Based Doublet Chemotherapy in Patients with EGFRm T790M NSCLC Who Have Progressed after EGFR...

por Mann, Helen, Andersohn, Frank, Bodnar, Carolyn, Mitsudomi, Tetsuya, Mok, Tony S. K., Yang, James Chih-Hsin, Hoyle, Christopher
Publicado 2017

Single-Cell Technologies to Study Phenotypic Heterogeneity and Bacterial Persisters

por Hare, Patricia J., LaGree, Travis J., Byrd, Brandon A., DeMarco, Angela M., Mok, Wendy W. K.
Publicado 2021

Transbronchial microwave ablation of lung nodules with electromagnetic navigation bronchoscopy guidance—a novel technique and initial experience with 30 cases

por Chan, Joyce W. Y., Lau, Rainbow W. H., Ngai, Jenny C. L., Tsoi, Carita, Chu, Cheuk Man, Mok, Tony S. K., Ng, Calvin S. H.
Publicado 2021

Transbronchial Techniques for Lung Cancer Treatment: Where Are We Now?

por Chan, Joyce W. Y., Siu, Ivan C. H., Chang, Aliss T. C., Li, Molly S. C., Lau, Rainbow W. H., Mok, Tony S. K., Ng, Calvin S. H.
Publicado 2023

The role of metabolism in bacterial persistence

por Amato, Stephanie M., Fazen, Christopher H., Henry, Theresa C., Mok, Wendy W. K., Orman, Mehmet A., Sandvik, Elizabeth L., Volzing, Katherine G., Brynildsen, Mark P.
Publicado 2014

Efficacy and Safety of S-1 Compared With Docetaxel in Elderly Patients With Advanced NSCLC Previously Treated With Platinum-Based Chemotherapy: A Subgroup Analysis of the EAST-LC T...

por Yang, James Chih-Hsin, Mok, Tony S.K., Lu, Shun, Nakagawa, Kazuhiko, Yamamoto, Nobuyuki, Shi, Yuan-Kai, Zhang, Li, Soo, Ross A., Morita, Satoshi, Tamura, Tomohide
Publicado 2021

A Randomized Assessor-Blinded Wait-List-Controlled Trial to Assess the Effectiveness of Acupuncture in the Management of Chemotherapy-Induced Peripheral Neuropathy

por Molassiotis, Alexander, Suen, Lorna K. P., Cheng, Hui Lin, Mok, T. S. K., Lee, Sara C. Y., Wang, C. H., Lee, Paul, Leung, Howan, Chan, V., Lau, T. K. H., Yeo, Winnie
Publicado 2019

Association of Immune-Related Adverse Events With Efficacy of Atezolizumab in Patients With Non–Small Cell Lung Cancer: Pooled Analyses of the Phase 3 IMpower130, IMpower132, and I...

por Socinski, Mark A., Jotte, Robert M., Cappuzzo, Federico, Nishio, Makoto, Mok, Tony S. K., Reck, Martin, Finley, Gene G., Kaul, Monika D., Yu, Wei, Paranthaman, Nindhana, Bāra, Ilze, West, Howard J.
Publicado 2023

30 Immunotherapy in advanced NSCLC—from the ‘tsunami’ of therapeutic knowledge to a clinical practice algorithm: results from an international expert panel meeting of the Italian A...

por de Marinis, Filippo, Ciardiello, Fortunato, Baas, Paul, Crinò, Lucio, Giaccone, Giuseppe, Grossi, Francesco, Hellmann, Matthew D, Mok, Tony S K, Lena, Hervè, Paz-Ares, Luis, Rodriguez-Abreu, Delvys, Von Pavel, Joachim, Gridelli, Cesare
Publicado 2018

KRAS G12C mutations in Asia: a landscape analysis of 11,951 Chinese tumor samples

por Loong, Herbert Ho-Fung, Du, Nan, Cheng, Chunyan, Lin, Hanqing, Guo, Jian, Lin, Gen, Li, Mingjiang, Jiang, Tao, Shi, Zhihua, Cui, Yanzhi, Jin, Xianfeng, Yao, Jicheng, Xing, Yutong, Yao, Ming, Wang, Kai, Mok, Tony S. K., Liu, Lunxu
Publicado 2020

Randomized controlled trial of S-1 versus docetaxel in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy (East Asia S-1 Trial in Lung Can...

por Nokihara, H, Lu, S, Mok, T S K, Nakagawa, K, Yamamoto, N, Shi, Y K, Zhang, L, Soo, R A, Yang, J C, Sugawara, S, Nishio, M, Takahashi, T, Goto, K, Chang, J, Maemondo, M, Ichinose, Y, Cheng, Y, Lim, W T, Morita, S, Tamura, T
Publicado 2017

Outcomes With Pembrolizumab Monotherapy in Patients With Programmed Death-Ligand 1–Positive NSCLC With Brain Metastases: Pooled Analysis of KEYNOTE-001, 010, 024, and 042

por Mansfield, Aaron S., Herbst, Roy S., de Castro, Gilberto, Hui, Rina, Peled, Nir, Kim, Dong-Wan, Novello, Silvia, Satouchi, Miyako, Wu, Yi-Long, Garon, Edward B., Reck, Martin, Robinson, Andrew G., Samkari, Ayman, Piperdi, Bilal, Ebiana, Victoria, Lin, Jianxin, Mok, Tony S.K.
Publicado 2021

A phase II clinical study on the efficacy and predictive biomarker of pegylated recombinant arginase on hepatocellular carcinoma

por Chan, Stephen L., Cheng, Paul N.M., Liu, Angela M., Chan, Landon L., Li, Leung, Chu, Cheuk M., Chong, Charing C.N., Lau, Yat M., Yeo, Winnie, Ng, Kelvin K.C., Yu, Simon C.H., Mok, Tony S.K., Chan, Anthony W.H.
Publicado 2021